Christopher Pauli is a molecular, cellular, and developmental biologist, who’s specialized in genomics, genetics, and transcriptomics of Cannabis and other non-model organisms. He has published eight peer-reviewed articles and has developed intellectual property that provides genetic tests and breeding applications of various cannabinoid synthase gene paralogs. His more recent focuses have been on understanding the underlying genetics of hermaphroditism and secondary metabolite production in Cannabis, specifically predicting the accumulation of cannabinoids, terpenes, and flavonoids. Christopher has worked in the Cannabis Research Industry for over 5 years and has grown and bred Cannabis since 2012. He’s worked with renowned researchers including Nolan Kane’s Laboratory, Cannabis Genomic Research Initiative, Agricultural Genomics Foundation, The Institute of Cannabis Research, Steep Hill’s Research and Development Team, and most recently with Front Range Biosciences’ Research and Development Team. At Front Range Biosciences, Christopher and his colleagues have published over 55 identified terpene synthase genes, which provides the basis of understanding needed to predict a given terpene profile. Additionally, Christopher works with both the bioinformatics and breeding teams at Front Range Biosciences to apply our scientific discoveries into breeding applications that let us develop new genetic combinations with our marker assisted breeding.